MARLBOROUGH, MASS., March 1, 2017 – Hologic, Inc. (Nasdaq: HOLX) will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including new solutions for biopsy workflow, at the European Congress of Radiology (ECR) in Vienna, Austria from March 1-5. Hologic also will host a symposium and several educational workshops throughout the show, giving attendees opportunities to experience screening and interventional products that offer unique patient and user benefits and address workflow challenges.
“As the only manufacturer with a core focus on innovating and advancing breast and musculoskeletal health, we look forward to our time at ECR as an opportunity to connect with the most dynamic minds in the global radiology community,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. “From hands-on workshops with new breast biopsy workflow solutions such as the Affirm™ prone biopsy system, to educational sessions offering real-time opportunities to engage with our cutting-edge technology, we are excited to share our suite of market-leading screening and interventional products with the world’s premier radiology professionals. At Hologic, we are committed to innovation supported by strong clinical evidence that delivers superior patient outcomes and optimal user workflow.”
Since its European launch at ECR in 2016, the Affirm prone system — the first dedicated prone biopsy system that is upgradable to allow 3D™ imaging-guided breast biopsies — has experienced positive clinical and patient feedback, with more than 95 percent of patients indicating in a post-procedure survey that the biopsy experience was faster, more comfortable and less painful than expected. The Affirm prone system provides clinicians with added confidence through superior imaging, 2D and 3D™ biopsy capability, faster and easier workflow, and seamless, 360-degree access to the breast.
Ad Statistics
Times Displayed: 172607
Times Visited: 3116 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
In addition to the Affirm prone system, Hologic will feature a number of other innovative products at ECR, including:
• The Affirm upright biopsy system for Selenia® Dimensions®, the proven 2D and 3D™ breast biopsy system providing superior upright biopsy performance;
• The new Affirm™ Lateral Arm accessory for upright biopsy, to improve access to challenging lesion locations and provide additional patient positioning options;
• Eviva® and ATEC® breast biopsy systems, designed to conduct minimally invasive biopsy procedures under stereotactic, tomosynthesis, ultrasound or MRI guidance;
